BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Glycogen Storage Disease Type Ia readouts · AssetMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Glycogen Storage Dise
 ase Type Ia\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06735755-10772@assetmemo.bio
DTSTAMP:20261121T004959Z
DTSTART;VALUE=DATE:20271230
DTEND;VALUE=DATE:20271231
SUMMARY:BEAM-301: Phase 1/2 readout est. (NCT06735755)
DESCRIPTION:BEAM-301\, phase 1/2\, Glycogen Storage Disease Type Ia.\nStudy
 : A Phase 1/2\, Dose-Exploration Study to Evaluate the Safety and Efficacy
  of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)\nEs
 timated primary completion: 30 December 2027. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/beam-301#upcoming-events\nRegistry record: https:
 //clinicaltrials.gov/study/NCT06735755
URL:https://assetmemo.bio/drug/beam-301#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
